© 2000 by European Society of Cardiology
Detection of ventricular fibrillation in implantable defibrillators with automatic gain control amplifiers
Effects of programming sensitivity
Kerckhoff-Clinic Bad Nauheim, Germany; 1Medical Clinic I Fulda, Germany
AIMS: In newer implantable cardioverter–defibrillators with automatic gain control amplifiers the maximum possible sensitivity is programmed with the aim of securing optimal detection of ventricular fibrillation. This study was designed to prove that a reduction in maximum sensitivity is safe with respect to appropriate sensing of ventricular fibrillation, while avoiding sensing of extracardiac signals.
METHODS AND RESULTS: Forty-two consecutive patients, undergoing defibrillator implantation/replacement with programmable maximum auto-gain sensing sensitivity (Ventak Mini IIITM, Ventak AVTM, Guidant, St. Paul, MN, U.S.A.), were prospectively investigated. Thirty-four patients were implanted with a dual-coil lead system, providing integrated bipolar sensing (EndotakTM, Guidant, St. Paul, MN, U.S.A.), eight patients received a single-coil lead system with true bipolar sensing (SprintTM, Medtronic, Minneapolis, MN, U.S.A.). During device implantation and pre-discharge testing, arrhythmia detection times of induced ventricular fibrillation were compared at programmed maximum (0·18 mV) and minimum (0·43 mV) sensitivity in a randomized manner. Seventy-six induced episodes of ventricular fibrillation were analysed. The mean arrhythmia detection times did not differ between the programmed sensing levels (maximum sensitivity: 1612±307 ms, vs minimal sensitivity: 1602±330 ms;P=ns). The results were not affected by the type of implanted lead system (integrated bipolar versus true bipolar sensing).
CONCLUSION: In the implantable defibrillator devices, reduction in maximum sensitivity did not impair the detection of induced episodes of ventricular fibrillation.
Key Words: Implantable defibrillator, automatic gain control, programmable sensitivity
Correspondence: Jörg Neuzner MD, FESC, Dept. of Cardiology, Kerckhoff-Clinic, Bad Nauheim, Beneke Strasse 2–8, D-61231 Bad Nauheim, Germany.
[1] Leitch JW, Yee R, Klein GJ, Jones DL, Murdock CJ. Correlation between the ventricular electrogram amplitude in sinus rhythm and in ventricular fibrillation. PACE 1990; 13: 1105–1109.
[2] Sperry RE, Ellenbogen KA, Wood MA, Stambler BS, DiMarco JP, Haines DE. Failure of a second and third generation implantable cardioverter defibrillator to sense ventricular tachycardia: implications for fixed-gain sensing devices. PACE 1992; 15: 749–755.
[3] Reiter MJ and Mann DE. Sensing and tachyarrhythmia detection problems in implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 1996; 7: 542–558.[Web of Science][Medline]
[4] Callans DJ, Hook BG, Kleimann RB, Mitra RL, Flores BT, Marchlinski FE. Unique sensing errors in third-generation implantable cardioverter-defibrillator. J Am Coll Cardiol 1993; 22: 1135–1140.[Abstract]
[5] Rosenthal ME and Paskmann C. Noise detection during bradycardia pacing with a hybrid nonthoracotomy implantable cardioverter defibrillator system: incidence and clinical significance. PACE 1998; 21: 1380–1386.
[6] Kelly PA, Mann DE, Damle RS, Reiter MJ. Oversensing during ventricular pacing in patients with a third-generation implantable cardioverter-defibrillator. J Am Coll Cardiol 1994; 23: 1531–1534.[Abstract]
[7] Brumwell DA, Kroll MW, Lehmann MH. The amplifier: sensing the depolarization. In Kroll MW and Lehmann MH (Eds.). Implantable cardioverter defibrillator therapy. The engineering-clinical interferenceNorwell, U S A Kluwer Academic Publishers pp. 275–392.
[8] Deshmukh P and Anderson K. Myopotential sensing by a dual chamber implantable cardioverter defibrillator: Two case reports. J Cardiovasc Electrophysiol 1998; 9: 767–772.[Web of Science][Medline]
[9] Neuzner J, Dürsch M, Sperzel J, Schwarz T, König S, Pitschner HF. Myopotential sensing: cause of inappropriate arrhythmia detection and device discharges in implantable defibrillator therapy (Abstr). PACE 1997; 20: 1225.
[10] Barold SS, Ong LSA, Falkoff MD, Heinle RA. Inhibition of bipolar demand pacemaker by diaphragmatic myopotentials. Circulation 1977; 56: 679–683.
[11] Ellenbogen KA, Wood MA, Stambler BS, Welch WJ, Damiano RJ. Measurement of ventricular electrogram amplitude during intraoperative induction of ventricular tachyarrhythmias. Am J Cardiol 1992; 70: 1017–1022.[Medline]
[12] Goldberger JJ, Horvath G, Donovan D, Johnson D, Challapalli R, Kadish AH. Detection of ventricular fibrillation by transvenous defibrillating leads: Integrated versus dedicated bipolar sensing. J Cardiovasc Electrophysiol 1998; 9: 677–688.[Medline]
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||